CAMZYOS
mavacamten
- Strength
- 15 mg/1
- Form
- Capsule, Gelatin Coated
- Class
- Cardiac Myosin Inhibitor
Myokardia, Inc.
Not stocked by us — reference only
mavacamten
Listed by Myokardia, Inc.
| Dosage form | Capsule, Gelatin Coated |
|---|---|
| Route | Oral |
| Drug class | Cardiac Myosin Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 73625-111 |
| FDA application | NDA214998 |
| RxNorm concept | 2600872 |
| Package sizes listed | 1 |
| Marketed since | April 2022 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
mavacamten
Myokardia, Inc.
Not stocked by us — reference only
mavacamten
Myokardia, Inc.
Not stocked by us — reference only
mavacamten
Myokardia, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.